NVTA NYSE
San Francisco, CA 94103
US
Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Nussbaum Robert L | F-InKind | 17,404 | $0.65 | 2023-12-20 |
| Brida Thomas | F-InKind | 17,404 | $0.65 | 2023-12-20 |
| Sholehvar David | A-Award | 850,000 | — | 2023-11-13 |
| Sholehvar David | 0 | — | 2023-11-13 | |
| Brida Thomas | A-Award | 229,500 | — | 2023-10-18 |